Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 10

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 10
---
 on September
29, 2025 (the “Effective Time”)
to effect a one-for-ten (1:10) reverse stock
split (the “Reverse Stock Split”)
of the shares of our Common Stock. The Reverse Stock Split was approved by our stockholders
at a special meeting of the stockholders onAugust
15, 2025.

As a result of the Reverse Stock
Split, every ten (10) shares of issued and outstanding Common
Stock were automatically combined into one (1)
issued and outstanding share of Common Stock, without
any change in the par value per share. No fractional shares were issued as a result of the
Reverse Stock Split, and any fractional
share resulting frm the Reverse Stock Split was rounded up to the next whole number. The shares of Common Stock underlying the outstanding
stock options and warrants were similarly adjusted along
with corresponding adjustments to their exercise
prices. The Reverse Stock Split also proportionally reduced the total
number of outstanding shares of Common Stock from 231,780,434 shares to 23,178,096 shares.

Nasdaq Listing Status

Nasdaq Minimum Bid Price Requi rement

On September 12, 2024, the Company
received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company
that for the prior 30 consecutive business days the bid price for the Company’s common stock had closed below the minimum $1.00
per share requirement for continued inclusion on Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (Bid Price Rule). The deficiency letter
did not result in the immediate delisting of the Company’s common stock from Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A),
the Company was provided an initial period of 180 calendar days, until March 11, 2025, to regain compliance with the Bid Price Rule.

<div align='center'>S-5</div>

On April 14, 2025, the Company
received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company
that for the prior 30 consecutive business days the bid price for the Company’s common stock had closed below the minimum $1.00
per share requirement for continued inclusion on Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (Bid Price Rule). The deficiency letter
did not result in the